// Biotech and Pharma Therapeutics
Mural Oncology wants to paint a new picture in IL-2 after Alkermes spinout
November 15, 2023 / Alkermes / Spinoff / Interleukin-2 / Solid Tumor
Mural Oncology, Alkermes’ cancer spinoff, has officially landed with $275 million in funding and a mission to develop an interleukin-2 (IL-2) candidate for solid tumors. Alkermes announced the plan to separate into two a year ago, with a spinout taking on the oncology work and the legacy company continuing in neuroscience.
Overheard in Africa: AI may be just what the doctor ordered for better healthcare, stronger society
November 15, 2023 / AI / Healthcare / Africa
According to the online Nigerian newspaper the Premium Times, a consensus emerged on that topic: “AI could be what Africa needs to build a resilient, society-wide primary healthcare system and ensure adequate and quality health services for all.”
Blue Shield of California, Mahmee Expand Maternal Health Partnership
November 10, 2023 / Blue Shield of California / Mahmee / Healthcare
Los Angeles-based Mahmee offers support during pregnancy, birth and postpartum, and focuses on marginalized communities. Each patient has a team of nurses, lactation consultants, doulas, mental health coaches, nutritionists and care coordinators. Patients can communicate with their care team through messages, group sessions and one-on-one appointments. They can also attend support groups and classes. The services are available virtually and in person at one of Mahmee’s clinics in California.
How to Leverage the Patient Journey for Market Strategy Development
November 15, 2023 / Healthcare / Patient Journey
GLP-1s are making headlines and are in high demand for their ability to help people lose weight, with five million prescriptions written in 2022. For many people who’ve struggled with obesity, they represent a transformational clinical advance. But what happens if the meds are no longer taken, whether due to high cost or side effects? The weight often comes back, sometimes with a vengeance.
Vertex, CRISPR gain ‘historic’ nod in UK for exa-cel. But will cost watchdogs embrace the gene-editing therapy?
November 16, 2023 / Vertex Pharmaceuticals / CRISPR / Sickle Cell Disease / Beta Thalassemia
// 4th Industrial Revolution
Inito, a startup that helps women quickly track fertility hormones at home, raises $6M
November 15, 2023 / Startup / Women’s Health / Fertility
Inito, a YC alum that helps women track fertility hormones quickly at home, has raised $6 million in Series A funding led by Fireside Ventures. The startup’s fertility monitor and kit is designed to give users easy-to-read fertility diagnostic results directly on their phone in just 10 minutes.
Medtech’s iPhone Moment: Pioneering Patient Experience-Focused Design in Medical Devices
November 15, 2023 / Medtech / Medical Devices / Apple
Edge Computing’s Role in Shaping the Future of Wearable Healthcare
November 15, 2023 / Healthcare / Wearable Devices / Remote Patient Monitoring
‘Medical-grade’ AI is poised to help health systems manage their data
November 15, 2023 / AI / ChatGPT / genAI
There’s been a lot of hype around generative artificial intelligence tools such as ChatGPT over the past year or so. But for all the emerging healthcare use cases involving large language models, it’s worth remembering that one major value of LLMs is their ability to improve natural language processing capabilities that have been around for decades.
Mercy’s AI-Powered Texting Platform Intercepts Chemo-Related Hospital Admissions
November 15, 2023 / AI / Chemo-Related / Chemotherapy / Patient
// Business & Markets
Gilead hands Arcellx $285M to expand BCMA cell therapy deal, sparking fresh push for congested market
November 15, 2023 / Gilead Sciences / Kite Pharma / Arcellx / Immuno-oncology
A gene editing biotech’s struggles end with reverse merger
November 15, 2023 / Gene Editing / Biotech / Merger / Lenz Therapeutics
Elucid scores $80M for AI imaging analysis software and more digital health fundings
November 10, 2023 / AI / Digital Health / Eleos Health / Elucid / Cardiovascular Disease
West Coast investor Red Tree on its San Diego expansion and staying bullish in biotech
November 16, 2023 / San Diego Biotech / Biotech / Cargo Therapeutics / Red Tree Venture Capital
Based in the San Francisco Bay Area, the fledgling firm pitched itself as a West Coast answer to deep-seeded biotechnology investment funds in Boston. Instead of drawing top-tier talent from Harvard and the Massachusetts Institute of Technology, it aimed to pull from institutions like Stanford and the University of California, Berkeley.
Pfizer’s cost-cutting campaign hits Sandwich site in UK, where 500 workers will lose jobs
November 14, 2023 / Pfizer / Layoffs / Job Cuts / United Kingdom
// Legal & Regulatory
FDA’s oncology office uses advisory committee to spotlight timely accelerated approval confirmation
November 15, 2023 / U.S. FDA / Accelerated Approval / FDA Advisory Commitee / Non-Hodgkin Lymphoma
FDA grants approval for first time to a home test for chlamydia and gonorrhea
November 15, 2023 / FDA / Drug Approval / Home Test
The Food and Drug Administration granted marketing approval to a home test for chlamydia and gonorrhea on Wednesday, the first such authorization of a home test to detect the two most common sexually transmitted infections in this country.
FDA skeptical of Merck’s gefapixant, even after cough recount
November 16, 2023 / Merck & Co / FDA Advisory Committee / FDA / GSK
Bristol Myers’ $4.1B Turning Point buy yields FDA approval for lung cancer drug Augtyro
November 16, 2023 / Bristol Myers Squibb / U.S FDA / FDA Approvals / Non-small Cell Lung Cancer
Navigating the Challenges of HIPAA Compliance in the Digital Age
November 16, 2023 / HIPAA / Digital Age / HIPAA
HIPAA compliance is a topic that weighs heavily on the healthcare industry and for a good reason. The issue is far more nuanced than it appears. Among these, the right of access provision — part of the HIPAA regulations — is one that often goes overlooked. It’s not just the major breaches that make the headlines; numerous breaches go unreported simply because patients are either unaware of their rights or unwilling to come forward.
// Research & Development
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
November 15, 2023 / Novo Nordisk / Eli Lilly / Wegovy / Zepbound
Real-world evidence in pharmaceutical drug development – faster, safer and more relevant?
November 13, 2023 / Drug Development / New Drugs / Pre-Clinical Trials
The cost of innovation is high. Pharmaceutical drug development requires significant upfront investment and long-lead development programs. And yet, only a small fraction of these programs succeed in the form of new drug approvals.
Study shows how congenital heart disease affects blood supply before birth
November 15, 2023 / Heart Disease / Birth Defect / CHD
New womb cancer test could prevent need for invasive diagnostic procedures
November 9, 2023 / Womb Cancer / Healthcare
Type 2 diabetes prevention programs can work at large scale, study finds
November 15, 2023 / Type 2 Diabetes / Clinical Trials
CancerX Startup Accelerator launched with White House support
November 14, 2023 / White House / CancerX / Startup
CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.
Co-hosted by Moffitt Cancer Center and Digital Medicine Society (DiMe), it cites its purpose as bringing together a number of stakeholders to ‘unlesh the power of innovation to fight cancer’.
House moves to limit so-called gain-of-function research
November 15, 2023 / House / New Bills / National Institutes of Health
House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.
3 things to know about the prescription drug bill the Mass. Senate could vote on this week
November 13, 2023 / Massachusetts Senate / Prescriptions / Drug Cost
The Massachusetts Senate is expected to vote on a bill Wednesday that would lower drug costs in the state while holding pharmaceutical companies accountable for price hikes.
Michigan bill that would pare back pharma liability shield law moves closer to enactment
November 13, 2023 / Michigan Bill / New Bill / Legislation
What health policies could hitch a ride on a spending bill?
November 14, 2023 / Spending Bill / Healthcare